Updated: February 7, 2026
How Does Metaxalone Work? Mechanism of Action Explained in Plain English
Author
Peter Daggett

Overview
How does Metaxalone (Skelaxin) actually relax muscles? The answer is more complex than you might think. Here's the science explained in plain English.
Is Metaxalone in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Metaxalone near you.
Metaxalone (Skelaxin) has been prescribed for over 60 years, yet its precise mechanism of action is still not fully understood. This might seem surprising for a medication that's been around since 1962, but it reflects a broader truth about centrally acting muscle relaxants: the science of how they produce their effects is genuinely complex — and in some ways, still being figured out.
Here's what we do know, explained in plain English.
What Metaxalone Does NOT Do
Let's start with a common misconception. Despite being called a "muscle relaxant," Metaxalone does NOT directly relax skeletal muscles. It doesn't:
- Act directly on muscle fibers
- Block neuromuscular transmission (like curare or the drugs used during surgery)
- Depress neuronal conduction in the peripheral nervous system
- Work like a local anesthetic to numb the muscles directly
All of these would be "peripherally acting" mechanisms. Metaxalone's action is central — it works in the brain and spinal cord.
Check live stock now.
What Metaxalone Actually Does: Central Nervous System Depression
Metaxalone is classified as a CNS depressant — a drug that slows down activity in the central nervous system. This means it reduces the overall "noise" of neural signals, which includes the signals that trigger and maintain muscle spasm.
When you have acute muscle pain from a strain or injury, a cycle develops: pain leads to muscle guarding, which leads to more spasm, which leads to more pain. Metaxalone interrupts this cycle not by blocking signals at the muscle, but by broadly calming activity in the CNS, reducing the neural "traffic" that sustains the spasm.
The FDA's prescribing information for Metaxalone states: "The mode of action of this drug has not been clearly identified, but may be related to its sedative properties." This is the official position — the drug works, but we're not completely sure exactly how.
The Emerging Science: MAO-A Inhibition and Serotonin
More recent research has shed additional light on how Metaxalone works — and why it can cause serotonin syndrome when combined with certain other drugs. Studies suggest that Metaxalone inhibits monoamine oxidase A (MAO-A), an enzyme that breaks down serotonin in the body. At therapeutic doses, Metaxalone appears to exert dose-dependent MAO-A inhibition, which means it slows down the breakdown of serotonin.
This MAO-A inhibition may contribute to Metaxalone's muscle-relaxing effects — serotonin plays a role in pain modulation and motor control. It also explains why combining Metaxalone with other serotonin-increasing drugs (like SSRIs, SNRIs, or certain opioids) can trigger serotonin syndrome, a potentially dangerous buildup of serotonin in the body.
How Metaxalone Is Processed by the Body
Understanding the pharmacokinetics (how the drug moves through your body) helps explain both its effects and its interactions:
- Absorption: Well absorbed from the GI tract. Bioavailability increases significantly when taken with food — meaning you absorb more of the drug with a meal than on an empty stomach.
- Onset: Effects typically begin within about 1 hour of taking the tablet.
- Peak: Maximum blood concentration reached at approximately 3 hours.
- Duration: Effects last approximately 4–6 hours, which is why it's taken 3–4 times daily.
- Metabolism: Extensively metabolized in the liver via multiple CYP enzymes, including CYP1A2, CYP2D6, CYP2E1, CYP3A4, and others. This multi-enzyme metabolism is relevant for drug interactions.
- Elimination: Excreted in the urine as unidentified metabolites. Half-life is 2–4 hours (fed state) or 8–9 hours (fasted state).
Why Metaxalone Causes Less Drowsiness Than Other Muscle Relaxants
Metaxalone is consistently cited as the least sedating muscle relaxant in the centrally acting class. The reason isn't fully understood, but it likely relates to the selectivity of its CNS effects. Cyclobenzaprine, for example, has a tricyclic structure similar to antidepressants, which gives it significant anticholinergic and antihistaminic activity — both of which cause sedation. Carisoprodol is metabolized into meprobamate, a sedating compound. Metaxalone lacks these secondary mechanisms, which may explain why its sedation burden is lower.
The Bottom Line on How It Works
Metaxalone works as a centrally acting CNS depressant that reduces the neural activity driving muscle spasm. Its precise mechanism remains incompletely understood, but likely involves general CNS depression plus possible MAO-A inhibition that modulates serotonin. It does not directly act on muscles at all. For more on what Metaxalone is used for and how to take it, see our comprehensive guide: What Is Metaxalone? Uses, Dosage, and What You Need to Know.
Frequently Asked Questions
Metaxalone typically begins working within approximately 1 hour of taking a tablet. Peak effects occur around 3 hours after ingestion. The full effect is felt as the drug reaches peak blood concentration. If you take it with food, absorption is faster and the peak concentration is higher than on an empty stomach.
No. Despite being called a muscle relaxant, Metaxalone does not directly act on muscle tissue. It works centrally — in the brain and spinal cord — by broadly depressing CNS activity, which reduces the neural signals that drive muscle spasm. The muscle relaxation is indirect, a result of reduced neural drive.
Metaxalone lacks the secondary pharmacological properties that make other muscle relaxants more sedating. Cyclobenzaprine has anticholinergic and antihistaminic activity (both sedating); carisoprodol is metabolized into the sedative meprobamate. Metaxalone appears to produce CNS depression more selectively, without these additional sedating mechanisms — though the exact reason for its lower sedation burden is not fully understood.
Research suggests that Metaxalone inhibits monoamine oxidase A (MAO-A), an enzyme that breaks down serotonin. At therapeutic doses, this may cause a modest increase in serotonin levels. When Metaxalone is combined with other drugs that also increase serotonin (SSRIs, SNRIs, opioids, triptans, TCAs), the combined effect can push serotonin levels dangerously high, causing serotonin syndrome.
Food increases the absorption of Metaxalone from the GI tract, leading to higher peak blood concentrations than when taken on an empty stomach. The exact reason relates to how food affects GI motility and drug solubility. This is why taking Metaxalone with food intensifies its CNS effects — your body is simply absorbing more of the drug.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Metaxalone also looked for:
More about Metaxalone
37,914 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





